Scattolin 2016 Abstract Mito Xmas Meeting Innsbruck: Difference between revisions
Beno Marija (talk | contribs) No edit summary |
No edit summary Β |
||
(2 intermediate revisions by the same user not shown) | |||
Line 5: | Line 5: | ||
|event=Mito Xmas Meeting 2016 Innsbruck AT | |event=Mito Xmas Meeting 2016 Innsbruck AT | ||
|abstract=Approximately 20% of T-cell acute lymphoblastic leukemia (T-ALL) patients do not respond to current therapy, and their clinical outcome is dismal. | |abstract=Approximately 20% of T-cell acute lymphoblastic leukemia (T-ALL) patients do not respond to current therapy, and their clinical outcome is dismal. | ||
Β | |||
In the present study we show that leukemic cells isolated from T-ALL patients as well as cell lines stabilized ''in vitro'' or propagated ''in vivo'' as xenografts exhibit high levels of mitochondrial reactive oxygen species (ROS). Interestingly, raising mitochondrial ROS using NS1619, a small molecule that opens the mitochondrial BK K<sup>+</sup> channel, induced death of leukemic cells from T-ALL patients and T-ALL cell lines but not of primary normal thymocytes or PBMC. These effects were enhanced by blunting ROS-scavenging pathways with dehydroepiandrosterone (DHEA), an inhibitor of the pentose phosphate pathway (PPP). The combination of NS1619 and DHEA led to proteolytic processing of OPA1, an inner mitochondrial membrane protein that controls cristae remodeling, cytochrome c release and apoptosis. OPA1 cleavage was dependent upon both ROS and the OMA1 mitochondrial protease. Furthermore, OPA1 cleavage induced by treatment with NS1619 and DHEA primed T-ALL cells to apoptosis induced by TNF-Related Apoptosis Inducing Ligand (TRAIL). | |||
These findings suggest that engaging the OMA1-OPA1 axis by raising mitochondrial ROS may prove to be an effective strategy for apoptotic priming of refractory T-ALL, which poses a major clinical challenge at present. | These findings suggest that engaging the OMA1-OPA1 axis by raising mitochondrial ROS may prove to be an effective strategy for apoptotic priming of refractory T-ALL, which poses a major clinical challenge at present. | ||
}} | }} | ||
{{Labeling | {{Labeling | ||
|area=mt-Structure;fission;fusion | |||
|diseases=Cancer | |||
|injuries=Cell death, Oxidative stress;RONS | |||
|organism=Human | |||
|tissues=Blood cells, Lymphocyte | |||
|preparations=Intact cells | |||
|event=B2, Oral | |event=B2, Oral | ||
|additional=Labelled by author | |||
}} | }} | ||
== Affiliations == | == Affiliations == |
Latest revision as of 17:50, 14 December 2016
Mitochondrial reactive oxygen species prime T-cell acute lymphoblastic leukemia to cell death by engaging the OMA1-OPA1 axis. |
Link:
Silic-Benussi M, Scattolin G, Cavallari I, Minuzzo S, Basso G, Indraccolo S, DβAgostino DM, Ciminale V (2016)
Event: Mito Xmas Meeting 2016 Innsbruck AT
Approximately 20% of T-cell acute lymphoblastic leukemia (T-ALL) patients do not respond to current therapy, and their clinical outcome is dismal.
In the present study we show that leukemic cells isolated from T-ALL patients as well as cell lines stabilized in vitro or propagated in vivo as xenografts exhibit high levels of mitochondrial reactive oxygen species (ROS). Interestingly, raising mitochondrial ROS using NS1619, a small molecule that opens the mitochondrial BK K+ channel, induced death of leukemic cells from T-ALL patients and T-ALL cell lines but not of primary normal thymocytes or PBMC. These effects were enhanced by blunting ROS-scavenging pathways with dehydroepiandrosterone (DHEA), an inhibitor of the pentose phosphate pathway (PPP). The combination of NS1619 and DHEA led to proteolytic processing of OPA1, an inner mitochondrial membrane protein that controls cristae remodeling, cytochrome c release and apoptosis. OPA1 cleavage was dependent upon both ROS and the OMA1 mitochondrial protease. Furthermore, OPA1 cleavage induced by treatment with NS1619 and DHEA primed T-ALL cells to apoptosis induced by TNF-Related Apoptosis Inducing Ligand (TRAIL). These findings suggest that engaging the OMA1-OPA1 axis by raising mitochondrial ROS may prove to be an effective strategy for apoptotic priming of refractory T-ALL, which poses a major clinical challenge at present.
Labels: MiParea: mt-Structure;fission;fusion Pathology: Cancer Stress:Cell death, Oxidative stress;RONS Organism: Human Tissue;cell: Blood cells, Lymphocyte Preparation: Intact cells
Event: B2, Oral Labelled by author
Affiliations
- Silic-Benussi M(1,2), Scattolin G(1), Cavallari I(1), Minuzzo S(1), Basso G(3), Indraccolo S(2), DβAgostino DM(4), Ciminale V(1,2)
- Dept Surgery, Oncology, Gastroenterology, Univ Padova, Italy
- Istituto Oncologico Veneto-IRRCS, Padova, Italy
- Dept Woman Child Health, Haemato-Oncology Division, Univ Padova, Italy
- Dept Biomedical Sc, Univ Padova, Italy